As a medical institution with independent legal qualification，Independent clinical laboratory（ICL）mainly provides services such as clinical examinations and pathological diagnosis to other medical institutions through cooperation with them. ICL may reduce inspection costs of clinical examinations and improve inspection efficiency and specialization of laboratories through intensive management. ICL in developed countries such as Europe，America and Japan has been well developed and stably run，while ICL in China has only a history of more than 20 years. In recent years，with continuous promulgation of incentive policies by national government and progress of medical technology，ICL in China has been developed rapidly，but the overall market share of ICL is still very small. ICL in China still faces some challenges and mechanism problems. It is necessary to further standardize and optimize the industrial environment.As a leading enterprise of ICL in China，Kingmed company has accumulated useful experiences in collectivization，chain and large-scale laboratory running. It provides high-quality and efficient services for medical institutions through continuous innovation and improvement for service models，and therefore Kingmed company may provide experience of management for developing ICL in China.